HS Code:
The category 'Syringes, with or without needles; parts and accessories thereof' falls under HS Code 901831. This category includes medical syringes used for injections, aspirations, and other medical procedures, as well as their components such as needles, plungers, and barrels. These products are critical in healthcare settings for administering medications, vaccines, and drawing blood. The global trade of syringes has seen significant growth due to rising healthcare demands, vaccination campaigns, and advancements in medical technology.
Total Trade Volume
USD 6.8 billion
Data from 2022
Source
United Nations Comtrade Database
Average Rate
4.5%
Highest Rate
12% (applied by certain developing countries)
Lowest Rate
0% (under free trade agreements like EU-USMCA)
Increased demand for disposable syringes
Driven by infection control measures and global vaccination drives, leading to higher production and trade volumes.
2020-2022
Shift towards safety syringes
Growing adoption of syringes with needlestick prevention features due to regulations in North America and Europe, boosting innovation and trade in advanced products.
2019-2022
Rising production in Asia
Countries like China and India are becoming major exporters due to lower production costs, impacting global price competition.
2018-2022
The unprecedented demand for syringes during the COVID-19 vaccine rollout led to a surge in exports, with countries like China and the US ramping up production and trade.
2021-2022
Increased trade volume by over 30% in key markets, though supply chain bottlenecks caused temporary shortages.
The EU's Medical Device Regulation (MDR) came into full effect, requiring syringe manufacturers to meet enhanced safety and quality standards for market access.
May 2021
Higher compliance costs for exporters to the EU, potentially reducing trade from non-compliant manufacturers.
Ongoing trade disputes led to additional tariffs on Chinese syringe exports to the US, prompting diversification of supply chains to other countries like Vietnam and India.
2022
Slight reduction in Chinese market share in the US, with increased costs passed to consumers.